—
C+
C+ The full Closelook — membership. Open the C+ overview

Insulet Corporation (PODD) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Insulet Corporation

PODD in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Insulet makes wearable insulin pumps for people with diabetes who need constant insulin dosing. Its main product, Omnipod 5, is a tubeless pod that links wirelessly to a third-party glucose sensor and adjusts insulin delivery automatically. An older version, Omnipod DASH, uses a handheld controller instead of full automation. It also makes a version of its pod for Amgen's chemotherapy support device. Insulet sells through pharmacies and distributors and is based in Acton, Massachusetts.
Where it sits in the stack
Insulet has no seat in our chip-and-infrastructure index; it sits in the diary's HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, which groups regulated device makers with long product cycles.
Who it is priced against
Closelook's peer group places it with other device and diagnostics names built on regulatory moats — Intuitive Surgical, Stryker, DexCom, IDEXX Laboratories, Globus Medical, Sonova and Sartorius; the market also names Medtronic, whose insulin pumps compete directly with Omnipod.
Why Closelook tracks it
It holds a seat in HALO Growth 100 but carries no Closelook score yet, and the diary has not quoted it in any recent edition.
What the diary watches
Whether Omnipod 5's automatic dosing keeps taking pump share as glucose-sensor makers widen who they connect with, since that link decides how much of the diabetes market runs through Insulet's pods.

Insulet Corporation (PODD) trades on US exchanges. Constituent of HALO Growth 100.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for PODD, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against PODD on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Insulet Corporation (PODD)?

Insulet Corporation trades as PODD on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-18.

Is PODD in a Closelook index?

Yes — Insulet Corporation is a constituent of HALO Growth 100, as of 2026-09-18.

Where does PODD trade against its moving averages?

Downtrend stack: Trades -6.3% vs the 50-day and -30.1% vs the 200-day average, 60.1% below the 52-week high and +12% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Insulet Corporation do?

Insulet makes wearable insulin pumps for people with diabetes who need constant insulin dosing. Its main product, Omnipod 5, is a tubeless pod that links wirelessly to a third-party glucose sensor and adjusts insulin delivery automatically. An older version, Omnipod DASH, uses a handheld controller instead of full automation. Closelook's peer group places it with other device and diagnostics names built on regulatory moats — Intuitive Surgical, Stryker, DexCom, IDEXX Laboratories, Globus Medical, Sonova and Sartorius; the market also names Medtronic, whose insulin pumps compete directly with Omnipod.

Where does Insulet Corporation sit in the AI build-out?

Insulet has no seat in our chip-and-infrastructure index; it sits in the diary's HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve, which groups regulated device makers with long product cycles. It holds a seat in HALO Growth 100 but carries no Closelook score yet, and the diary has not quoted it in any recent edition.

What does this page show?

A live price chart with SMA overlays and drawing tools for PODD, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe